Cargando…
miRNA-22 as a Candidate Diagnostic Biomarker for Coronary Slow Flow
BACKGROUND: Coronary slow flow (CSF) refers to the phenomenon of delayed distal flow in the absence of lesions detected on coronary angiography. Although the detection rate of CSF has been increasing in clinical practice, early diagnosis is difficult and the factors contributing to this condition re...
Autores principales: | Chen, Tong, Wang, Zhen-Yu, Li, Chuan-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399758/ https://www.ncbi.nlm.nih.gov/pubmed/32774915 http://dx.doi.org/10.1155/2020/7490942 |
Ejemplares similares
-
Circulating miRNA-155 as a Potential Biomarker for Coronary Slow Flow
por: Su, Qiang, et al.
Publicado: (2018) -
Plasma Choline as a Diagnostic Biomarker in Slow Coronary Flow
por: Zhu, Yuan-Ting, et al.
Publicado: (2020) -
Identification of Candidate miRNA Biomarkers for Glaucoma
por: Hindle, Allyson G., et al.
Publicado: (2019) -
Diagnostic and prognostic value of circulating miRNA‐499 and miRNA‐22 in acute myocardial infarction
por: Wang, Xiaoqing, et al.
Publicado: (2020) -
Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer
por: Zhang, Wenyu, et al.
Publicado: (2014)